Search results
Gateway - Quartz
Quartz· 3 days agoThe millennial-skewed telehealth platform Hims & Hers announced Monday that is now offering customers a compounded version of semaglutide, the active ingredient in popular weight< ...
Gateway - Quartz
Quartz· 3 days agoPharma giant AstraZeneca aims to increase its revenue by a...cost-cutting initiative as the company struggles with diminishing demand for its COVID-19 vaccine. A U.S. Food ...
The Surprising Reason You’re Not Losing Weight Even With Strength Training
Women's Health via Yahoo News· 7 days agoGaining muscle mass, inadequate rest, and inconsistency may prevent you from losing weight even if...
3 Growth Stocks You Can Buy Right Now Without Any Hesitation
Motley Fool via Yahoo Finance· 6 days agoIts portfolio of new brands includes Zepbound for weight loss, Mounjaro for obesity, cancer medicine...
The 8 Best Meal Delivery Services, According to Our Testers
Men's Journal· 3 days agoPrepared meal delivery services can help you save time and eat healthily. We’ve rounded up our picks...
American diets improve, but remain poor for many, Tufts study says
United Press International via Yahoo News· 4 days ago"Food insecurity affects diet quality via lower consumption of healthier foods, especially those...
Gateway - Quartz
Quartz· 4 days agoThe Danish company has filed several lawsuits in the US against certain medical spas, weight loss or wellness clinics, and compounding pharmacies, some ...
Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?
Zacks via Yahoo Finance· 2 days agoThe cash position, which also looks good, should enable TERN to fund its development programs. As of...
The Best Biotech Stock to Invest $1,000 in Right Now
Motley Fool via Yahoo Finance· 3 days agoIn particular, no matter which of its pipeline programs get approved for sale, assuming any of them ever do, it'll have to fight the current...
Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?
Zacks· 2 days agoTerns Pharmaceuticals, Inc. (TERN) outperforms the industry year to date on encouraging pipeline progress of its oncology candidate.
